EXPRESSION OF MULTIDRUG RESISTANCE GENES IN PATIENTS WITH NEWLY DIAGNOSED AND REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Chernykh, Y. [1 ]
Golenkov, A. [1 ]
Shushanov, S.
Rybalkina, E. [2 ]
Mitina, T. [1 ,2 ]
Trifonova, E. [1 ]
Vysotskaya, L. [1 ]
Kataeva, E. [1 ]
机构：
[1] Russian Acad Med Sci, State Budgetary Healthcare Inst Moscow Area Mosco, Moscow, Russia
[2] Russian Acad Med Sci, FGBU Russian Canc Res Ctr, Moscow, Russia
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1852
引用
收藏
页码：731 / 732
页数：2
相关论文
共 50 条
  • [1] Effect of Expression of Multidrug Resistance Genes in Newly Diagnosed Multiple Myeloma on the Clinical Course of the Disease
    Chernykh, Yulia
    Golenkov, Anatoly
    Vysotskaya, Lyudmila
    Shushanov, Sain
    Rybalkina, Ekaterina
    [J]. BLOOD, 2016, 128 (22)
  • [2] PROGNOSTIC SIGNIFICANCE OF EXPRESSION OF MULTIDRUG RESISTANCE GENES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH BORTEZOMIB-CONTEINING THERAPHY
    Chernykh, Y.
    Golenkov, A.
    Vysotskaya, L.
    Belousov, K.
    [J]. HAEMATOLOGICA, 2016, 101 : 794 - 794
  • [3] Mutations In Thirty Hotspot Genes In Newly Diagnosed Chinese Multiple Myeloma Patients
    Hu, Ying
    Chen, Wenming
    Wang, Jingbo
    [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 9999 - 10010
  • [4] Oprozomib in patients with newly diagnosed multiple myeloma
    Hari, Parameswaran
    Matous, Jeffrey V.
    Voorhees, Peter M.
    Shain, Kenneth H.
    Obreja, Mihaela
    Frye, John
    Fujii, Hisaki
    Jakubowiak, Andrzej J.
    Rossi, Davide
    Sonneveld, Pieter
    [J]. BLOOD CANCER JOURNAL, 2019, 9 (9)
  • [5] Oprozomib in patients with newly diagnosed multiple myeloma
    Parameswaran Hari
    Jeffrey V. Matous
    Peter M. Voorhees
    Kenneth H. Shain
    Mihaela Obreja
    John Frye
    Hisaki Fujii
    Andrzej J. Jakubowiak
    Davide Rossi
    Pieter Sonneveld
    [J]. Blood Cancer Journal, 9
  • [6] New developments in the management and treatment of newly diagnosed and relapsed/refractory multiple myeloma patients
    van de Donk, Niels W. C. J.
    Lokhorst, Henk M.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (12) : 1569 - 1573
  • [7] Selinexor, Lenalidomide and Dexamethasone (SRd) for Patients with Relapsed/Refractory and Newly Diagnosed Multiple Myeloma
    White, Darrell J.
    LeBlanc, Richard
    Baljevic, Muhamed
    Bahlis, Nizar J.
    Lentzsch, Suzanne
    Venner, Christopher P.
    Gasparetto, Cristina
    Chen, Christine I.
    Lipe, Brea
    Tuchman, Sascha A.
    Sutherland, Heather J.
    Kotb, Rami
    Sebag, Michael
    Callander, Natalie S.
    Bensinger, William I.
    Rossi, Adriana C.
    Sheehan, Heidi
    Van Domelen, Dane
    Zhou, Tianjun
    Kazuharu, Kai
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    Schiller, Gary J.
    [J]. BLOOD, 2020, 136
  • [8] Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients
    Broyl, Annemiek
    Hose, Dirk
    Lokhorst, Henk
    de Knegt, Yvonne
    Peeters, Justine
    Jauch, Anna
    Bertsch, Uta
    Buijs, Arjan
    Stevens-Kroef, Marian
    Beverloo, H. Berna
    Vellenga, Edo
    Zweegman, Sonja
    Kersten, Marie-Josee
    van der Holt, Bronno
    el Jarari, Laila
    Mulligan, George
    Goldschmidt, Hartmut
    van Duin, Mark
    Sonneveld, Pieter
    [J]. BLOOD, 2010, 116 (14) : 2543 - 2553
  • [9] INTENSITY OF EXPRESSION OF MULTIDRUG RESISTANCE GENES AFFECT ON THE OVERALL SURVIVAL OF PATIENTS WITH MULTIPLE MYELOMA WERE TREATED WITH BORTEZOMIB AND ASSOCIATED WITH THE INITIAL MULTIDRUG RESISTANCE
    Chernykh, Y.
    Golenkov, A.
    Vysotskaya, L.
    Belousov, K.
    [J]. HAEMATOLOGICA, 2017, 102 : 774 - 774
  • [10] Epigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma Patients
    Roy Choudhury, Samrat
    Ashby, Cody
    Zhan, Fenghuang
    van Rhee, Frits
    [J]. CANCERS, 2021, 13 (24)
12345